NCT03093688 2025-07-02
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Recruiting
Clinical Trials
10 trialsNCT06527898 2024-09-19
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06479473 2024-08-09
Radiotherapy to All Residual Lesions After Chemoimmunotherapy
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT05269485 2024-06-25
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06454890 2024-06-12
Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06136910 2023-11-18
Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Unknown
NCT05882630 2023-05-31
Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting
NCT04199559 2019-12-16
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer
Henan Cancer Hospital
Phase 1/2 Unknown
NCT01027676 2013-11-14
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
National Cancer Center, Korea
Phase 1/2 Unknown
NCT00874328 2010-10-25
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Phase 1/2 Unknown